THE CURRENT STATUS OF CHEMOTHERAPY OF SYSTEMIC FUNGAL DISEASE
- 1 December 1959
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 51 (6), 1220-1229
- https://doi.org/10.7326/0003-4819-51-6-1220
Abstract
In actinomycotic infections, penicillin is still the most effective chemotherapy. Sulfadiazine in combination with an antibiotic is recommended in cases of nocardiosis. Iodides and vaccine therapy have been the major therapeutic measures recommended in cases of aspergillosis. Iodides are also standard treatment for sporotrichosis, geotrichosis and penicilliosis. There is little experience in the therapy of mucormycosis, and success has been achieved in a few cases by the surgical removal of the focus of infection, or by the control of an underlying disease, e.g., diabetes. In the treatment of histoplasmosis and blastomycosis, amphotericin appears to be effective. Amphotericin, similarly, seems to be the best drug thus far for cryptococcosis. Amphotericin is least effective in systemic coccidi-oidomycosis and candidiasis, but worthy of use in the absence of other, effective chemotherapy.Keywords
This publication has 5 references indexed in Scilit:
- THE DISEASE SPECTRUM OF HUMAN HISTOPLASMOSISAnnals of Internal Medicine, 1958
- Promising results in cryptococcal meningitisNeurology, 1958
- NORTH AMERICAN BLASTOMYCOSIS: A CLINICAL STUDY OF 40 CASESAnnals of Internal Medicine, 1956
- A STUDY OF NORTH AMERICAN BLASTOMYCOSIS AND ITS TREATMENT WITH STILBAMIDINE AND 2-HYDROXYSTILBAMIDINEAnnals of Internal Medicine, 1955
- ASCOSIN IN THE TREATMENT OF EXPERIMENTAL HISTOPLASMOSIS IN MICE1953